University of Georgia Researchers will research development of a vaccine for use in the event of a biological warfare attack with funding from a $1.1 million grant.
The grant from the U.S. Department of defense is for three years.
Researchers will focus on vaccines against glanders and melioidosis that could be delivered as an airborne infection. Bacteriologist Eric Lafontaine and immunologist Jeff Hogan will lead the project.
Glanders is rare in humans but affects a wide variety of animals in the Middle East, Asia, Africa and South America. It has been involved in biowarfare experiments. Melioidosis is found in Southeast Asia and northern Australia.
